1 87100sek
-0,1 %
Date:2026-02-25Time:10:40:16Latest report:Q4-2025List:Large CapTicker:AZN
Market Cap:2 901 818 msekEnterprise Value:3 117 485 msekNet Sales:58 739 musdEarnings:10 225 musdEmployees:0ISIN:GB0009895292

Ratios

10-year key figure history for AstraZeneca turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AstraZeneca with index and moving average MA50 and MA200.

Stockprice:1 866,50
MA50:1 733,52
MA200:1 551,79
Price/MA200:20,3 %
RSI (14):66,5
Price/MA50:7,7 %

Description

AstraZeneca is a global pharmaceutical company focused on the research, development and marketing of prescription medicines, primarily for the treatment of diseases in the therapeutic areas of respiratory, cardiovascular/metabolic and cancer. In addition to its core business, the company also has a focus on the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in all global regions and is headquartered in Cambridge, UK.

Pharmaceuticals